After more than 15 years of setbacks, Mesoblast has finally secured its first FDA approval, and early signs suggest the commercial rollout is gaining traction.

"I was scared to death because I didn't have a heart for months." A man surviving without a real heart got a lucky break -- ...

AI in healthcare India, Generative AI medical documentation, discharge summary AI, Dr Urvi Shukla Aditya Birla Hospital, ...

Juan Uribe is urgently seeking a stem cell donor for his 15-year-old son, Max, who has a rare blood disorder Max’s heritage ...

Could wounded skin someday regrow perfectly without scars? A new study by Harvard stem cell biologists published in Cell ...

TetiAI releases Lucid — the first open-source cognitive protection system for AI, built on 30+ peer-reviewed studies, ...

New RNA therapy uses a single skeletal muscle shot to help the heart heal itself after a heart attack, repairing damage and ...

Japan's approval of the world’s first medical treatments using reprogrammed human cells signals a new era in regenerative ...

Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to ...

Scientists at UCSF invented a microscopic “womb” material for growing artificial organs (organoids) from scratch.

Artificial intelligence may be transforming pharmaceutical research, but it will not compress drug development timelines as ...

UCSF received $824 million from the National Institutes of Health (NIH) in 2025 to drive the discovery, translational, and clinical science that leads to new treatments for disease and advances U.S.